250 related articles for article (PubMed ID: 34964693)
1. Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma
Patras L; Ionescu AE; Munteanu C; Hajdu R; Kosa A; Porfire A; Licarete E; Rauca VF; Sesarman A; Luput L; Bulzu P; Chiroi P; Tranca RA; Meszaros MS; Negrea G; Barbu-Tudoran L; Potara M; Szedlacsek S; Banciu M
Cancer Biol Ther; 2022 Dec; 23(1):1-16. PubMed ID: 34964693
[TBL] [Abstract][Full Text] [Related]
2. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.
Yu KF; Zhang WQ; Luo LM; Song P; Li D; Du R; Ren W; Huang D; Lu WL; Zhang X; Zhang Q
Int J Nanomedicine; 2013; 8():2473-85. PubMed ID: 23885174
[TBL] [Abstract][Full Text] [Related]
3. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
[TBL] [Abstract][Full Text] [Related]
4. Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis.
Negrea G; Rauca VF; Meszaros MS; Patras L; Luput L; Licarete E; Toma VA; Porfire A; Muntean D; Sesarman A; Banciu M
Front Pharmacol; 2022; 13():870347. PubMed ID: 35450036
[TBL] [Abstract][Full Text] [Related]
5. The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
Licarete E; Rauca VF; Luput L; Patras L; Sesarman A; Banciu M
Oncol Rep; 2019 Dec; 42(6):2694-2705. PubMed ID: 31578578
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
[TBL] [Abstract][Full Text] [Related]
7. Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin in vitro resulting in improved antitumor activity in vivo.
Xiong XB; Huang Y; Lu WL; Zhang H; Zhang X; Zhang Q
Pharm Res; 2005 Jun; 22(6):933-9. PubMed ID: 15948037
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles derived from dendritic cells loaded with VEGF-A siRNA and doxorubicin reduce glioma angiogenesis in vitro.
Shamshiripour P; Rahnama M; Nikoobakht M; Rad VF; Moradi AR; Ahmadvand D
J Control Release; 2024 May; 369():128-145. PubMed ID: 38522817
[TBL] [Abstract][Full Text] [Related]
9. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time.
Kooijmans SAA; Fliervoet LAL; van der Meel R; Fens MHAM; Heijnen HFG; van Bergen En Henegouwen PMP; Vader P; Schiffelers RM
J Control Release; 2016 Feb; 224():77-85. PubMed ID: 26773767
[TBL] [Abstract][Full Text] [Related]
10. Combining Doxorubicin-Loaded PEGylated Poly(Lactide-co-glycolide) Nanoparticles with Checkpoint Inhibition Safely Enhances Therapeutic Efficacy in a Melanoma Model.
Chitphet K; Geary SM; Chan CHF; Simons AL; Weiner GJ; Salem AK
ACS Biomater Sci Eng; 2020 May; 6(5):2659-2667. PubMed ID: 33463284
[TBL] [Abstract][Full Text] [Related]
11. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes].
Zhao B; Fan YC; Wang XQ; Dai WB; Zhang Q; Wang XL
Yao Xue Xue Bao; 2013 Mar; 48(3):417-22. PubMed ID: 23724658
[TBL] [Abstract][Full Text] [Related]
12. Adhesion between EVs and tumor cells facilitated EV-encapsulated doxorubicin delivery via ICAM1.
Wang S; Qiao C; Kong X; Yang J; Guo F; Chen J; Wang W; Zhang B; Xiu H; He Y; Wang J; Feng H; Cai Z
Pharmacol Res; 2024 Jul; 205():107244. PubMed ID: 38821149
[TBL] [Abstract][Full Text] [Related]
13. Improved delivery of doxorubicin using rationally designed PEGylated platinum nanoparticles for the treatment of melanoma.
Mukherjee S; Kotcherlakota R; Haque S; Bhattacharya D; Kumar JM; Chakravarty S; Patra CR
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110375. PubMed ID: 31924026
[TBL] [Abstract][Full Text] [Related]
14.
Diril M; Özdokur KV; Yıldırım Y; Karasulu HY
Pharm Dev Technol; 2023 Dec; 28(10):915-927. PubMed ID: 37921920
[TBL] [Abstract][Full Text] [Related]
15. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived extracellular vesicles for the active targeting and effective treatment of colorectal tumors
Nguyen VD; Kim HY; Choi YH; Park JO; Choi E
Drug Deliv; 2022 Dec; 29(1):2621-2631. PubMed ID: 35941835
[TBL] [Abstract][Full Text] [Related]
17. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.
Cao D; Zhang X; Akabar MD; Luo Y; Wu H; Ke X; Ci T
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):181-191. PubMed ID: 30686051
[TBL] [Abstract][Full Text] [Related]
18. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy.
Zou Y; Fang Y; Meng H; Meng F; Deng C; Zhang J; Zhong Z
J Control Release; 2016 Dec; 244(Pt B):326-335. PubMed ID: 27245309
[TBL] [Abstract][Full Text] [Related]
19. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X
Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
